Literature DB >> 21266456

APP-dependent up-regulation of Ptch1 underlies proliferation impairment of neural precursors in Down syndrome.

Stefania Trazzi1, Valentina Maria Mitrugno, Emanuele Valli, Claudia Fuchs, Simona Rizzi, Sandra Guidi, Giovanni Perini, Renata Bartesaghi, Elisabetta Ciani.   

Abstract

Mental retardation in Down syndrome (DS) appears to be related to severe neurogenesis impairment during critical phases of brain development. Recent lines of evidence in the cerebellum of a mouse model for DS (the Ts65Dn mouse) have shown a defective responsiveness to Sonic Hedgehog (Shh), a potent mitogen that controls cell division during brain development, suggesting involvement of the Shh pathway in the neurogenesis defects of DS. Based on these premises, we sought to identify the molecular mechanisms underlying derangement of the Shh pathway in neural precursor cells (NPCs) from Ts65Dn mice. By using an in vitro model of NPCs obtained from the subventricular zone and hippocampus, we found that trisomic NPCs had an increased expression of the Shh receptor Patched1 (Ptch1), a membrane protein that suppresses the action of a second receptor, Smoothened (Smo), thereby maintaining the pathway in a repressed state. Partial silencing of Ptch1 expression in trisomic NPCs restored cell proliferation, indicating that proliferation impairment was due to Ptch1 overexpression. The overexpression of Ptch1 in trisomic NPCs resulted from increased levels of AICD [a transcription-promoting fragment of amyloid precursor protein (APP)] and increased AICD binding to the Ptch1 promoter. Our data provide novel evidence that Ptch1 overexpression underlies derangement of the Shh pathway in trisomic NPCs with consequent proliferation impairment. The demonstration that Ptch1 overexpression in trisomic NPCs is due to an APP fragment provides a link between this trisomic gene and the defective neuronal production that characterizes the DS brain.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21266456     DOI: 10.1093/hmg/ddr033

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  51 in total

Review 1.  Trisomy 21 and early brain development.

Authors:  Tarik F Haydar; Roger H Reeves
Journal:  Trends Neurosci       Date:  2011-12-09       Impact factor: 13.837

2.  DYRK1A overexpression enhances STAT activity and astrogliogenesis in a Down syndrome mouse model.

Authors:  Nobuhiro Kurabayashi; Minh Dang Nguyen; Kamon Sanada
Journal:  EMBO Rep       Date:  2015-09-15       Impact factor: 8.807

Review 3.  Prospects for improving brain function in individuals with Down syndrome.

Authors:  Alberto C S Costa; Jonah J Scott-McKean
Journal:  CNS Drugs       Date:  2013-09       Impact factor: 5.749

4.  Hedgehog agonist therapy corrects structural and cognitive deficits in a Down syndrome mouse model.

Authors:  Ishita Das; Joo-Min Park; Jung H Shin; Soo Kyeong Jeon; Hernan Lorenzi; David J Linden; Paul F Worley; Roger H Reeves
Journal:  Sci Transl Med       Date:  2013-09-04       Impact factor: 17.956

5.  Deficiency of patched 1-induced Gli1 signal transduction results in astrogenesis in Swedish mutated APP transgenic mice.

Authors:  Ping He; Matthias Staufenbiel; Rena Li; Yong Shen
Journal:  Hum Mol Genet       Date:  2014-07-15       Impact factor: 6.150

6.  Osthole Protects Bone Marrow-Derived Neural Stem Cells from Oxidative Damage through PI3K/Akt-1 Pathway.

Authors:  Yu-Hui Yan; Shao-Heng Li; Hong-Yan Li; Ying Lin; Jing-Xian Yang
Journal:  Neurochem Res       Date:  2016-10-12       Impact factor: 3.996

Review 7.  Amyloid Precursor Protein (APP) Metabolites APP Intracellular Fragment (AICD), Aβ42, and Tau in Nuclear Roles.

Authors:  Gerhard Multhaup; Otmar Huber; Luc Buée; Marie-Christine Galas
Journal:  J Biol Chem       Date:  2015-08-21       Impact factor: 5.157

8.  The Longest Amyloid-β Precursor Protein Intracellular Domain Produced with Aβ42 Forms β-Sheet-Containing Monomers That Self-Assemble and Are Proteolyzed by Insulin-Degrading Enzyme.

Authors:  Claire A Krasinski; Qiuchen Zheng; Valerie A Ivancic; Donald E Spratt; Noel D Lazo
Journal:  ACS Chem Neurosci       Date:  2018-08-03       Impact factor: 4.418

9.  OLIG2 over-expression impairs proliferation of human Down syndrome neural progenitors.

Authors:  Jie Lu; Gewei Lian; Hui Zhou; Giuseppe Esposito; Luca Steardo; Laurent C Delli-Bovi; Jonathan L Hecht; Q Richard Lu; Volney Sheen
Journal:  Hum Mol Genet       Date:  2012-02-17       Impact factor: 6.150

Review 10.  SHH desmoplastic/nodular medulloblastoma and Gorlin syndrome in the setting of Down syndrome: case report, molecular profiling, and review of the literature.

Authors:  Ross Mangum; Elizabeth Varga; Daniel R Boué; David Capper; Martin Benesch; Jeffrey Leonard; Diana S Osorio; Christopher R Pierson; Nicholas Zumberge; Felix Sahm; Daniel Schrimpf; Stefan M Pfister; Jonathan L Finlay
Journal:  Childs Nerv Syst       Date:  2016-07-21       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.